Chengdu Kanghong Pharmaceutical Group Co. Ltd. A | Ownership
Companies that own Chengdu Kanghong Pharmaceutical Group Co. Ltd. A
China Universal Asset Management Co., Ltd.
5,480,958
1.14%
611,976
0.31%
03/31/2018
Baoying Fund Management Co., Ltd.
2,954,500
0.62%
-1,119,816
0.77%
03/31/2018
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
2,799,648
0.59%
-360,769
0.49%
12/31/2017
Fuanda Fund Management Co., Ltd.
1,853,452
0.39%
1,853,452
3.62%
12/31/2017
Chang Xin Asset Management Co., Ltd.
937,222
0.2%
-1,300,301
0.25%
12/31/2017
Harvest Fund Management Co., Ltd.
864,061
0.18%
299,496
0.04%
12/31/2017
Soochow Asset Management Co., Ltd.
527,250
0.11%
353,568
0.61%
12/31/2017
Zhong Ou Asset Management Co., Ltd
422,732
0.09%
422,732
0.05%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
418,367
0.09%
-94,137
0.21%
12/31/2017
Bosera Asset Management Co., Ltd.
400,069
0.08%
400,069
0.02%
12/31/2017
About Chengdu Kanghong Pharmaceutical Group Co.
View Profile
| Address |
No. 36 Shuxi Road
Chengdu Sichuan 610036
China
|
|
Employees
|
- |
| Website |
http://www.cnkh.com |
| Updated |
07/08/2019 |
| Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, manufacture and distribution of biological products, traditional Chinese medicines, and chemical drugs. Its products include conbercept ophthalmic injection, songling xuemaikang jiaonang, shugan jieyu jiaonang, kenuoxin jiaonang, danshu jiaonang, yiqing jiaonang, venlafaxine hydrochloride capsules and sustained-release tablets, aripiprazole tablets and orally disintergrating tablets, mosapride citrate dispersible tablets, and dexzopiclone tablet. The company was founded on October 3, 1996 and is headquartered in Chengdu, China. |
